| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns—Results of a non-interventional study of the DeCOG
|
Hillen, Uwe
|
|
2018
|
96 |
C |
p. 34-43
|
artikel
|
| 2 |
A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification—Defining novel predictive and prognostic markers in stage III colon cancer
|
Margalit, Ofer
|
|
2018
|
96 |
C |
p. 105-110
|
artikel
|
| 3 |
A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur–uracil versus surgery alone in stage II colon cancer: SACURA trial
|
Matsuda, Chu
|
|
2018
|
96 |
C |
p. 54-63
|
artikel
|
| 4 |
Checkpoint blockade after kidney transplantation
|
Lesouhaitier, Mathieu
|
|
2018
|
96 |
C |
p. 111-114
|
artikel
|
| 5 |
Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT
|
Giebel, Sebastian
|
|
2018
|
96 |
C |
p. 73-81
|
artikel
|
| 6 |
Corrigendum to “An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint®)” [Eur J Cancer 75 (April 2017) 5–13]
|
Makama, M.
|
|
2018
|
96 |
C |
p. 131-132
|
artikel
|
| 7 |
Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1
|
Mekki, Ahmed
|
|
2018
|
96 |
C |
p. 91-104
|
artikel
|
| 8 |
Diagnostic value of 18F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site
|
Wolpert, Fabian
|
|
2018
|
96 |
C |
p. 64-72
|
artikel
|
| 9 |
Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure
|
Necchi, Andrea
|
|
2018
|
96 |
C |
p. 128-130
|
artikel
|
| 10 |
First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13)
|
Wicki, Andreas
|
|
2018
|
96 |
C |
p. 6-16
|
artikel
|
| 11 |
Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study
|
Nabieva, N.
|
|
2018
|
96 |
C |
p. 82-90
|
artikel
|
| 12 |
Next generation neuro-oncology
|
Weller, Michael
|
|
2018
|
96 |
C |
p. 1-5
|
artikel
|
| 13 |
Persisting inequalities in survival patterns of childhood neuroblastoma in Southern and Eastern Europe and the effect of socio-economic development compared with those of the US
|
Panagopoulou, Paraskevi
|
|
2018
|
96 |
C |
p. 44-53
|
artikel
|
| 14 |
Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer: A systematic review
|
Goey, Kaitlyn K.H.
|
|
2018
|
96 |
C |
p. 115-124
|
artikel
|
| 15 |
Risk stratification of sentinel node–positive melanoma patients defines surgical management and adjuvant therapy treatment considerations
|
Verver, Daniëlle
|
|
2018
|
96 |
C |
p. 25-33
|
artikel
|
| 16 |
The new world of biosimilars in oncology: Translation of data to the clinic
|
Rugo, Hope S.
|
|
2018
|
96 |
C |
p. 125-127
|
artikel
|
| 17 |
Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort
|
Gobbini, Elisa
|
|
2018
|
96 |
C |
p. 17-24
|
artikel
|
Tijdschrift beschrijving